Purpose: To estimate the dynamics of cerebral oxygenation and metabolism during intracranial pressure (ICP) correction with 15% Mannitol and 7,2% saline in 6% HES 200/0,5.
Brain edema is the main cause of intracranial hypertension in patients with intracranial hemorrhage. In turn, intracranial hypertension aggravates brain edema by altering cerebral perfusion and cerebral venous blood outflow [1] [2] [3] . Therefore intracranial pressure (ICP) correction is one of the main goals of intensive care in patients with intracranial hemorrhage. Infusion of hyperosmolar solutions is common therapy of intracranial hypertension [4, 5] . Hyperosmolar solutions increase the osmolar gradient between plasma and cerebral interstitium, and lead to fluid moving from the brain to intravascular space. Infusion of hyperosmolar solutions is accompanied by hypervolemia and reduces blood viscosity, that cause transient increase of cerebral blood flow and reflex vasoconstriction.
The most popular hyperosmolar agents used for intracranial hypertension correction are mannitol (15% and 20%) and hypertonic saline (3%, 7.5%, 10%). To increase the duration of their action hyperosmolar solutions are combined with colloids.
In spite of a large amount of investigations, data about hyperosmolar solutions influence on the ICP, systemic hemodynamics and mortality are controversial. There are only few studies, in which effects of mannitol were compared with hypertonic saline [6] . R. Vialet et al., 2003 found that in patients with severe traumatic brain injury (TBI) 7,5% saline was more effective in intracranial hypertension treatment than 20% mannitol [7] . C. Battison et al., 2005 investigated the effects of equimolar doses of 20% mannitol and 7,5% saline in 6% dextran-70 in patients with TBI and aneurismal subarachnoid hemorrhage (SAH). Authors mentioned that hypertonic saline combined with colloid solution reduced ICP more effectively than mannitol [8] .
Information about effects of hyperosmolar solutions on cerebral oxygenation and metabolism is very small. P.G. Al-Rawi et al., 2005 showed increase of brain oxygen tension and decrease of lactate/pyruvate ratio at 60 min after reducing the intracranial hypertension with hypertonic saline in patients with poor grade SAH [9] . O.W. Sakowitz et al., 2007 didn't find changes in brain oxygen tension after ICP correction with 20% mannitol, but showed 10 -40% increase of intracerebral glucose, lactate, pyruvate and glutamate levels in patients with severe TBI [10] .
The aim of our study was to estimate the dynamics of cerebral oxygenation and metabolism during intracranial hypertension correction with 15% mannitol and 7.2% saline in 6% HES 200/0,5.
MATERIALS AND METHODOLOGY
Investigation was approved by local ethical committee.
We analyzed 39 episodes of increased ICP correction with hyperosmolar solutions in 9 patients with intracranial hemorrhage and Glasgow Coma Score 4-8. Four patients were with aneurismal SAH and 5 patients -with severe TBI ( Table 1 ). All patients were operated on. Mean age was 45 ± 17 years, male/female ratio -5/4.
In all patients with SAH the linear blood flow velocity in middle brain arteries (MBA) was determined by transcranial dopplerography ("MultiDop T", DWL Elektronische Systeme GmbH, Germany). Severe vasospasm (blod flow velocity in the left and right MBA more than 200 cm/sec) was observed in all patients.
Monitoring of ICP, systemic hemodynamics, oxygen saturation in the internal jugular vein bulb (SvjO 2 ) and cerebral microdialysis was used in all patients. Brain temperature (Tbr) and brain oxygen tension (PbrO 2 ) were investigated in five patients.
ICP Monitoring
The special double-lumen catheter with a balloon at the edge («Air-Pouch Probe, 3XL», Germany) was placed in anterior horn of right or left lateral ventricle for intraventricular ICP measurement. Measuring lumen of catheter was connected to the monitoring system «Spiegelberg: BrainPressure Monitor» (Germany), draining lumen -to the CSF drainage system. For intraparenchymatous ICP measurement «Codman MicroSensor TM » probe (USA) was used. Probes were placed in the frontal or temporal lobe of unlesioned brain hemisphere and connected to the «Codman ICP Express» monitor (USA).
Hemodynamic Monitoring
Systemic hemodynamics was estimated by transpulmonary thermodilution («PiCCOplus», Pulsion Medical Systems, Germany). One of the subclavian or internal jugular veins was catheterized and special thermistor-tipped catheter (Pulsiocath PV2015L20 «Pulsion Medical Systems», Germany) was placed in femoral artery. Arterial access allowed continuous monitoring of hemodynamic values and arterial blood sampling. Transpulmonary thermodilution was performed at all stages of the study ( Table 2) . Arterial blood pressure transducer was fixed on the level of foramen Monro (the middle of the length between external orbit angle and external acoustic meatus).
Jugular Oxymetry
For SvjO 2 measurement central venous catheter was placed into bulb of jugular vein. The position of catheter was verified via side view X-ray of cervix. Venous blood probes were analyzed in the laboratory (Gas analyzer "ABL 800", Radiometr, Denmark). 
Cerebral Microdialysis
Cerebral microdialysis catheters (CMA 70, membrane length 10mm, pore diameter 20000 Da, Sweden) were inserted through the drill hole or special fixation device ("bolt") into "lesioned" (in patients with TBI -brain tissue near primary lesion, in patients with ASAH -brain tissue perfused by involved artery) and "intact" brain tissue (Fig. 1) . Catheters location was confirmed by X-ray computer tomography (CT).
Catheter was perfused with CNS Perfusion Fluid (CMA Microdialysis, Sweden) at rate 0,3 μL/min using CMA 107 perfusion pumps (CMA Microdialysis, Sweden) after the insertion. It took approximately 17 min to accumulate enough volume of dialysate. Vials with dialysate were placed into «ISCUS Clinical Microdialysis Analyser» (CMA Microdialysis, Sweden) to measure glucose, glycerol, lactate and piruvate concentrations ( Table 3) .
Monitoring of Brain Oxygen Pressure and Brain Temperature
Polarographic PbrO 2 electrodes («REVOXODE Brain Oxygen Catheter-Micro-Probe», Integra Lifesciences, Germany) and brain temperature probes («TRERMOCOUPLE Brain Temperature Catheter-Micro-Probe», Integra Lifesciences, Germany) were placed into "lesioned" and "intact" brain tissue through special fixation device ("bolt"). Probes location in the brain was confirmed by CT. Probes were connected to «LICOX CMP Tissue Oxygen Pressure Monitor» (Integra Lifesciences, Germany).
Patient Management
Standard intensive care was used for all patients. Infusion therapy was based on combination of colloid and crystalloid solutions. Decision about infusion therapy volume and structure was based on invasive homodynamic monitoring data. Enteral feeding (20-25 kkal/kg/day) was started on the first day after the admission to the ICU. Nitrogen balance was calculated for protein requirement evaluation. Parenteral nutrition was added if necessary. Artificial lung ventilation with tidal volume 8-10 ml/kg of ideal body mass and PEEP 5 cmH 2 0 was administered in all cases. Target PaCO 2 level was 30-40 mmHg. Head-edge of the bed was elevated to 30-40º. Analgetic and sedative drugs (propofol infusion (3 -6 mg/kg/hour) or bolus dosing of midazolam (0,15-0,25 mg/kg) with nalbufine 200 -300 (mkg/kg)) were used during invasive procedures (tracheotomy, vessel catheterizations), to achieve target PaCO 2 level and in patients with psychomotor agitation. 
Pyruvate (μcmol/l) 166 ± 47
Lactate (mmol/l) 2,9 ± 0,9
Lactate/pyruvate ratio 23 ± 4
Glycerol (μcmol/l) 80 ± 40
Study Design
Persistent elevation (during 15-20 minutes) of intracranial pressure above 20 mmHg, tolerant to routine methods of ICP correction (elevation of the bed head-edge, maintenance of normothermia and normoxia, PaCO 2 30-35 mmHg, analgesia and sedation) was the indication for hyperosmolar solutions infusion.
Intravenous infusion of 15% Mannitol (Biochimik, Russian Federation), 400 ml (0,5 -1 g/kg) during 15-20 min (n=22) or "HyperHAES" (7,2% NaCl in 6% HES 200/0,5) (Fresenius Kabi Deutschland GmbH, Germany), 250 ml (2 -4 ml/kg) during 5-15 min (n=17) were used for ICP reduction in accordance with intrahospital protocol.
Each patient received infusion of both solutions. For example -first medication was 15% Mannitol, second -"HyperHAES", third -15% Mannitol etc. Patients were randomized to receive 15% Mannitol or "HyperHAES" first. In 5 patients first medication was 15% Mannitol first, in four -"HyperHAES". Minimal interval between infusions of different solutions was 120 min.
The arterial hemoglobin concentration (Hb), ICP, mean arterial blood pressure (MAP), heart rate (HR), arterial blood temperature (Tbl), Tbr, PbrO 2 , oxygen extraction ratio (O 2 ER), cardiac index (CI), cardiac function index (CFI), global end-diastolic volume index (GEDVI), stroke volume variation (SVV), systemic vascular resistance index (SVRI), cerebral perfusion pressure (CPP), SvjO 2 , PaO 2 , PaCO 2 , PaO 2 /FiO 2 , serum glucose concentration, glucose, lactate, pyruvate, glycerol concentrations and lactate/pyruvate ratio in cerebral interstitial fluid were measured before infusion and 30 and 120 min after it. Metabolites measured by cerebral microdialysis, Tbr and PbrO 2 were analyzed in "intact" (int) and "lesioned" (les) brain tissue.
Statistical Analysis
All the parameters investigated were compared between the groups ("Mannitol" vs "HyperHAES") and inside each group. Distribution normality was evaluated by Kolmogorov-Smirnov's criterion. Intragroup differences were evaluated with Wilcoxon's signed-rank test. Intergroup differences were evaluated with Mann-Whitney test. For all analyses p value of <0,05 was regarded as significant. Data are expressed as ± SD (M -mean, SD -standard deviation) if distribution was normal and as median (25 and 70 percentile) if distribution was abnormal.
RESULTS
FiO 2 , Hb, PaO 2 , PaCO 2 , PaO 2 /FiO 2 , Tbl and serum glucose concentration were stable and comparable between groups during the study ( Table 4) . 
Intracranial and Cerebral Perfusion Pressures
Mean ICP was 29 ± 5 mmHg before 15% Mannitol and "HyperHAES" infusions. Introduction of investigated solutions significantly decreased ICP at 30 and 120 min after infusion ( Table 5) . But "HyperHAES" had more pronounced effect on ICP than mannitol (Fig. 2) .
The duration of ICP reduction below 20 mmHg was 121 ± 58 min for 15% Mannitol and 258 ± 122 min for "Hyper-HAES" (p<0,001).
15% Mannitol administration was accompanied by significant increase of cerebral perfusion pressure at 30 min after infusion ( Table 5) . "HyperHAES" introduction increased significantly CPP at 30 and 120 min after infusion. 
Systemic Hemodynamics Parameters
Patients in both groups were normovolemic before infusion of the investigated solutions ( Table 6 ). 15% Mannitol infusion was accompanied by non-significant influence on systemic hemodynamics. "HyperHAES" administration increased significantly cardiac output and decreased slightly SVV at 30 min after infusion. Infusion of investigated solutions was not accompanied by significant dynamics of global end-diastolic volume and cardiac function.
Cerebral Oxygenation and Metabolism
Brain oxygen tension and cerebral metabolites levels were comparable between patients with TBI and ASAH before the investigation ( Table 7) . During investigation we observed the same dynamics of cerebral oxygenation and metabolism in patients with traumatic and nontraumatic intracerebral hemorrhage.
All studied episodes of intracranial hypertension were not accompanied by PbrO 2 reduction below ischemic threshold (15 mmHg) and significant increase of O 2 ER (Table 8, Figs.  3, 4) . Brain oxygen pressure was within normal values and was slightly higher in "intact" tissue.
Administration of the investigated solutions was associated with slight PbrO 2 increase in "intact" and "lesioned" brain tissue. However, "HyperHAES" administration significantly increased PbrO 2 (les) at 30min following infusion (Fig. 4) .
Brain temperature in "intact" and "lesioned" tissue was equal and did not change during the study. 15% Mannitol and "HyperHAES" infusion did not influence oxygen extraction ratio.
Reduction of glucose and pyruvate and slight increase of glycerol concentration in "lesioned" and "intact" brain tissue was observed initially in all patients (Table 8, Figs. 
5-8).
Lactate concentration was within normal values or nonsignificantly exceeded them. Lactate/pyruvate ratio exceeded normal values in "intact" and "lesioned" brain tissue.
15% Mannitol infusion did not change glucose, pyruvate concentrations and lactate/pyruvate ratio in "intact" and "lesioned" tissue.
HyperHAES administration was accompanied with significant increase of glucose concentration in "intact" and "lesioned" brain tissue (Figs. 5, 6 ). Glucose concentration in "lesioned" tissue at 120 min after "HyperHAES" infusion was significantly higher in comparison with 15% Mannitol (1,25 (0,8-1,4 ) mmol/l and 0,7 (0,5-1,0), mmol/l respectively) (Fig. 6) .
Pyruvate concentration increased in "intact" and in "lesioned" brain tissue as well (Figs. 7, 8) . Lactate concentration significantly increased in "intact" and "lesioned" areas, but was within normal values ( Table 8) .
Lactate/pyruvate ratio increased in "intact" tissue and did not change in "lesioned" areas.
15%
Mannitol and "HyperHAES" administration did not change the glycerol concentration in "intact" and "lesioned" brain tissue.
DISCUSSION
Intracranial hypertension correction with hyperosmolar solutions is a routine practice. The results of our study confirm significant ICP reduction after 15% Mannitol and "HyperHAES" infusion, but we observed significant difference in action duration of investigated solutions.
15% Mannitol infusion maintained ICP below 20 mmHg for 121 min, "HyperHAES" -for 258 min. This difference has vital importance in clinical conditions, because hyperosmolar agents may cause undesirable side-effects. Repeated Mannitol infusions could cause "rebound effect". Continuous administration of hyperosmolar agents increases serum osmolality and risk of renal failure [12] [13] [14] .
Important data were obtained during hemodynamics parameters analysis. All patients were normovolemic before hyperosmolar solutions administration (normal values of CI, GEDVI, SVRI). Infusion of investigated solutions did not influence systemic hemodynamics, with the exception of significant increase of cardiac output at 30 minutes after "HyperHAES" infusion. Before the beginning of the study we were worried about hypervolemia that can be caused by "HyperHAES" administration. However, this was not observed. 15% Mannitol and "HyperHAES" infusion increased cerebral perfusion pressure. However it was not associated with significant increase of brain oxygen pressure that testified to safe cerebral blood flow autoregulation in "intact" and "lesioned" brain tissue.
Intracranial hypertension was accompanied with glucose and pyruvate concentration reduction and lactate/pyruvate ratio increase in "intact" and "lesioned" brain tissue.
Brain energy demand is extremely high. Brain mass constitutes 2-3% of body mass, however, brain consumes 15% of cardiac output and 20-25% of total oxygen and glucose delivery [15] . Recent studies expanded the knowledge about cerebral metabolism in normal and ischemic conditions. Neuroglia and especially astrocytes play an important role in energy supplying of the brain [15] [16] [17] [18] . The processes of astrocytes directly contact to capillaries and form the blood-brain barrier (BBB). The major quantity of glucose goes directly into astrocytes, but not into neurons [15] . Glycolisis is the dominant process providing adenosine-three-phosphate (ATP) synthesis in astrocytes. Utilization of one glucose molecule provides formation of two pyruvate and two ATP molecules. ATP is used for maintenance of transmembrane ion gradients, ensuring functioning of ATP-dependent ion pumps (particularly + -Na + ATPase) [15, 19, 20] . + -Na + ATPase maintains high potassium and low sodium concentration within brain cells. The major quantity of pyruvate, produced as a result of glycolisis in astrocytes, is not included in threecarbonic acids cycle and does not undergo oxidative phosphorylation, but transforms to lactate, that escapes to interstitial space and goes into neurons [15, 16, 18] . Currently there are a lot of evidences that lactate, but not glucose, is the main substrate for neuronal nutrition. Lactate is transformed to pyruvate, which is oxidized in respiratory chain. This process results in 18 ATP molecules production from one molecule of pyruvate. Thus, decay of one glucose molecule leads to formation of 38 ATP molecules [15, 20] .
Sodium concentration in the brain interstitial space and in astrocytes plays the important role in cerebral metabolism. Glucose uptake from the blood is activated by increase of glutamate concentration inside the astrocytes. Glutamate uptake is associated with co-transport of 2-3 sodium ions. Thus, glutamate transport and activation of glucose uptake from the blood depends on sodium concentration in the brain interstitial space [15, 21] .
Decrease of glucose concentration in the cerebral interstitial space increases mortality and risk of severe neurological deficit [22, 23] .
Under anaerobic conditions, neuronal energy metabolism is maintained only due to glycolisis, since oxidation in respiratory chain requires oxygen. Glucose is splitted into pyruvate, with consequent transforming to lactate. Intensification of anaerobic glycolisis is accompanied with increase of lactate concentration and lactate/pyruvate ratio in brain interstitial space. But increase of lactate concentration and lactate/pyruvate ratio may occur even in normal oxygen delivery to brain tissue. This condition is defined as "metabolic crisis" and may be caused by mitochondrial dysfunction [24] .
Despite similar effects on systemic hemodynamics, the influence of investigated solutions on cerebral metabolism differed significantly. 15% Mannitol administration did not change the concentration of investigated metabolites in "intact" and "lesioned" brain tissue. Despite ICP reduction, the increase of CPP and normal brain oxygen pressure, intensity of glycolisis and oxidative phosphorilation stayed unchanged. Glucose and lactate concentrations remained significantly reduced during the study. Nevertheless, lactate concentration increased, despite the absence of significant dynamics in pyruvate concentration. It can be related to continued anaerobic glycolisis, and probably to mitochondrial dysfunction.
"HyperHAES" administration significantly increased glucose concentration in "intact" and "lesioned" brain tissue. Possibly, this effect was determined by prolong ICP reduction and increasing of CPP. However, such effects could be related to microcirculation improvement as a result of "HyperHAES" infusion [2, [25] [26] [27] . It is known, that hypertonic solutions of NaCl encourage the neurons membrane potential and maintain integrity of BBB [1, 28, 29] . We draw your attention to the fact, that "HyperHAES" infusion was accompanied by glycolisis activation in "intact" and "lesioned" brain tissue. However, piruvate concentration increase in the "lesioned" areas was more significant during the study. Pyruvate concentration increase was accompanied with rise of lactate concentration. Because significant increase in piruvate concentration in "lesioned" tissue was not accompanied with increase in lactate/pyruvate ratio it can be supposed that in "lesioned" areas pyruvate was oxydised in respiratory chain. In "intact" brain tissue oxidative phosphory-
